Results 141 to 150 of about 2,156 (206)

Recommendations for the Use of Sapropterin in Phenylketonuria [PDF]

open access: yesMolecular Genetics and Metabolism, 2012
Phenylketonuria (PKU) is an inherited disorder of phenylalanine (Phe) metabolism. Until recently, the only treatment for PKU was a Phe-restricted diet. Increasing evidence of suboptimal outcomes in diet-treated individuals, inconsistent PKU management practices, and the recent availability of tetrahydrobiopterin (BH(4)) therapy have fueled the need for
Elaina Jurecki, Jane Gillis, Amy Pender
exaly   +4 more sources

Use of Sapropterin in the Management of Phenylketonuria: Seven Case Reports

open access: yesMolecular Genetics and Metabolism, 2013
Sapropterin treatment, with or without dietary treatment, improves blood phenylalanine control, increases phenylalanine tolerance, and may reduce the day-to-day dietary treatment burden in a subset of patients with phenylketonuria (PKU). Balancing the need for maintained control of blood phenylalanine with diet relaxation is complex when administering ...
Júlio César Rocha   +2 more
exaly   +5 more sources

Sapropterin Dihydrochloride for Phenylketonuria and Tetrahydrobiopterin Deficiency

open access: yesExpert Review of Endocrinology and Metabolism, 2010
Sapropterin dihydrochloride is the first registered synthetic form of the naturally occurring cofactor and cosubstrate, tetrahydrobiopterin (BH4). It is essential for the conversion of phenylalanine (Phe) by phenylalanine-4-hydroxylase (PAH) to tyrosine.
Nenad Blau
exaly   +4 more sources

International Best Practice for the Evaluation of Responsiveness to Sapropterin Dihydrochloride in Patients With Phenylketonuria [PDF]

open access: yesMolecular Genetics and Metabolism, 2019
Phenylketonuria (PKU) is an inherited metabolic disease caused by phenylalanine hydroxylase (PAH) deficiency. As the resulting high blood phenylalanine (Phe) concentration can have detrimental effects on brain development and function, international ...
Javier de las Heras   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy